Repaglinide, a new oral antidiabetic agent: A review of recent preclinical studies

European Journal of Clinical Investigation, Supplement

Volumn 29, Issue 2, 1999, Pages 21-29

  Malaisse, W J ^a,b  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Glucagon; Insulin; Preclinical studies; Repaglinide; Somatostatin

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIDIABETIC AGENT; BENZOIC ACID DERIVATIVE; CALCIUM CHANNEL; CALCIUM ION; ESTER; GLIBENCLAMIDE; GLIMEPIRIDE; GLUCOSE; INSULIN; IONOPHORE; MEGLITINIDE; POTASSIUM CHANNEL; PROINSULIN; REPAGLINIDE; SUCCINIC ACID;

BIOSYNTHESIS; CALCIUM CELL LEVEL; CELL MEMBRANE; CONFERENCE PAPER; DEPOLARIZATION; DIABETES MELLITUS; EXTRACELLULAR CALCIUM; HUMAN; INSULIN BLOOD LEVEL; INSULIN LIKE ACTIVITY; INSULIN RELEASE; NONHUMAN; ORAL DRUG ADMINISTRATION; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

EID: 0033001413     PISSN: 0960135X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00001.x     Document Type: Conference Paper

References (34)

1. Malaisse WJ. Stimulation of insulin release by non-sulfonylurea hypoglycemic agents: the meglitinide family. Horm Metab Res 1995, 27: 263-6.
2. Louchami K, Laghmich A, Jijakli H, Mest H, Malaisse WJ. Secretory, biosynthetic and cationic responses to 2-(N-phenyl-indoyl) imidazole in rat pancreatic islets. Pharmacol Res 1998; 38: 305-10.
3. Louchami K, Jijakli H, Sener A, Jones RB, Malaisse WJ. Effect of 1,1-dimethyl-2-[2-morpholinophenyl] guanidine fumarate on pancreatic islet function. Eur J Pharmacol 1998; 352: 289-97.
4. Lins L, Brasseur R, Malaisse WJ. Conformational analysis of non-sultonylurca hypoglycemic agents of the meglitinide family. Biochem Pharmacol 1995; 50: 1879-84.
5. Fuhlendorff J, Rorsman P, Kofod H et al. Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes. Diabetes 1998; 47: 345-51.
6. Lins L, Brasseur R, Malaisse WJ. Conformational analysis of the calcium complexes formed by meglitinide analogs. Res Commun Mol Pathol Pharmacol 1995; 90: 153-64.
7. Bakkali-Nadi A, Malaisse-Lagae F, Malaisse WJ. Ionophoretic activity of meglitinide analogues. Diabetes Res 1994; 27: 61-71.
8. Bakkali-Nadi A, Malaisse-Lagae F, Malaisse WJ. Ionophoretic properties of the non-sulfonylurea hypoglycemic agents A-4166 and KAD-1229. Res Commun Mol Pathol Pharmacol 1995; 88: 339-47.
9. Malaisse WJ, Sener A. Effect of N-[(trans-4-isopropylcyclohexyl) -carbonyl]-D-phenylalanine on nutrient catabolism in rat pancreatic islets. Gen Pharmacol 1998; 31: 451-4.
10. Louchami K, Jijakli H, Sener A, Malaisse WJ. Effect of repaglinide upon nutrient metabolism, biosynthetic activity, cationic fluxes and insulin release in rat pancreatic islets. Res Commun Mol Pathol Pharmacol 1998; 99: 155-68.
11. Viñambres C, Villanueva-Peñacarrillo ML, Valverde I, Malaisse WJ. Repaglinide preserves nutrient-stimulated biosynthetic activity in rat pancreatic islets. Pharmacol Res 1996; 34: 83-5.
12. Viñambres C, Garcia-Martinez JA, Villanueva-Peñacarrillo ML, Valverde I, Malaisse WJ. Preservation of nutrient-stimulated biosynthetic activity in pancreatic islets exposed to a meglitinide analogue. Med Sci Res 1995; 23: 779-80.
13. Jijakli H, Malaisse WJ. Preservation of protein biosynthesis in rat pancreatic islets exposed to A-4166. Med Sci Res 1997; 25: 813-4.
14. Laghmich A, Ladrière L, Malaisse-Lagae F, Malaisse WJ. Pancreatic islet responsiveness to D-glucose after repeated administration of repaglinide. Eur J Pharmacol 1998; 348: 265-70.
15. Jijakli H, Ulusoy S, Malaisse WJ. Dissociation between the potency and reversibility of the insulinotropic action of two meglitinide analogues. Phamacol Res 1996; 34: 105-8.
16. Jijakli H, Ulusoy S, Malaisse WJ. Dynamics of the cationic and secretory responses to A-4166 in perifused pancreatic islets. Fundam Clin Pharmacol 1997; 11: 300-4.
17. Malaisse WJ, Sato F. Insulinotropic action of (2S) -2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate. I. Secretory and cationic aspects. Gen Pharmacol 1995; 26: 1313-8.
18. + concentrations. Pharmacol Res 1995; 32: 111-4.
19. 2+-induced insulin release. Med Sci Res 1995; 23: 371-2.
20. 45Ca uptake by subcellular fractions prepared from rat pancreatic islets. Med Sci Res 1995; 23: 843-4.
21. Lebrun P, Malaisse WJ. Cationic and secretory effects of glimepiride and glibenclamide in perifused rat islets. Pharmacol Toxicol 1992; 70: 357-60.
22. Malaisse WJ, Lebrun P. Iterative stimulation of pancreatic islets by glipizide. Pharmacol 1993; 46: 43-9.
23. 45Ca outflow and insulin release in pancreatic islets. Diabetes Res 1996; 31: 27-31.
24. Bakkali Nadi A, Malaisse-Lagae F, Malaisse WJ. Insulinotropic action of meglitinide analogs: concentration-response relationship and nutrient dependency. Diabetes Res 1994; 27: 81-7.
25. Leclercq-Meyer V, Ladrière L, Fuhlendorff J, Malaisse WJ. Stimulation of insulin and somatostatin release by two meglitinide analogs. Endocrine 1997; 7: 311-7.
26. Sener A, Malaisse-Lagae F, Ulusoy S, Leclercq-Meyer V, Malaisse WJ. Contrasting secretory behaviour of pancreatic islets from old rats in two models of non-insulin-dependent diabetes. Diabetes Res 1996; 31: 67-76.
27. Louchami K, Ladrière L, Jijakli H, Malaisse WJ. Effect of repaglinide on insulin secretion in islets from rats infused for two days with a Hypertonic solution of D-glucose. Endocrine 1998; 8: 247-50.
28. Marynissen G, Leclercq-Meyer V, Sener A, Malaisse WJ. Perturbation of pancreatic islet function in glucose-infused rats. Metabolism 1990; 39: 87-95.
29. Akkan AG, Malaisse WJ. Iterative pulse administration of succinic acid monomethyl ester to streptozotocin diabetic rats. Diabetes Res 1993; 23: 55-63.
30. Leclercq-Meyer V, Malaisse WJ. Opposite effects of D-glucose and 2-ketoisocaproate upon insulin release by the isolated perfused pancreas removed from hyperglycemic rats. Endocrine J 1994; 2: 265-71.
31. García-Martínez JA, Villanueva-Peñacarrillo ML, Valverde I, Björkling F, Malaisse WJ. Stimulation of insulin release and potentiation of the insulinotropic action of antidiabetic agents by 1,2,3 tri (methylsuccinyl) glycerol ester in anaesthetized rats. Pharmacol Res 1997; 36: 369-72.
32. Malaisse WJ. The beta cell in NIDDM: giving light to the blind. Diabetologia 1994; 37 (Suppl. 2): S36-42.
33. Ladrière L, Malaisse-Lagae F, Fuhlendorff J, Malaisse WJ. Repaglinide, glibenclamide and glimepiride administration to normal and hereditarily diabetic rats. Eur J Pharmacol 1997; 335: 227-34.
34. Ladrière L, Malaisse-Lagae F, Fuhlendorff J, Malaisse WJ. Effect of antidiabetic agents on the increase in glycemia and insulinemia caused by refeeding in hereditarily diabetic rats. Res Commun Mol Pathol Pharmacol 1997; 97: 53-9.